Becker's 11th Annual Health IT + Revenue Cycle Conference made one thing clear this week. The conversation around enterprise clinical AI has moved past adoption and into accountability. Across sessions on ambient documentation, revenue cycle intelligence, and workforce management, a consistent thread emerged: health systems that deployed AI quickly are now asking harder questions about how to govern, evaluate, and sustain it.
Three pressing observations from the show map directly to questions health system leaders should already be asking any enterprise AI vendor.
Attendees repeatedly noted that organizations are rolling out AI tools faster than they can build the processes to monitor, evaluate, and course-correct them. The systems pulling ahead are not necessarily the ones with the most algorithms. They are the ones with governance structures durable enough to outlast any single model or vendor relationship. This is precisely why operational analytics and governance visibility, including utilization, adoption, outcomes, drift, and system-wide performance, belong on any enterprise AI evaluation checklist as a core requirement rather than a nice-to-have.
One of the sharper points raised was that every AI pilot needs an expiration date. Without a defined success threshold set before launch, pilots quietly become fixtures that consume staff attention without ever proving measurable value. That discipline should extend to vendor selection itself. Does the platform demonstrate measurable operational and financial impact, such as throughput, transfer optimization, and workflow efficiency, or does it ask health systems to take algorithm performance on faith?
As agentic AI takes on tasks once performed by people, the questions shift from IT to workforce management. Leaders now need to know who supervises the tool, what happens when it breaks, and who is accountable when it misbehaves. That shift underscores why post-go-live partnership matters as much as the technology itself. A platform is only as strong as the ongoing, vendor-led optimization, education, and operational alignment behind it.
These are not abstract concerns. They are the same evaluation criteria that separate point solutions from long-term enterprise platforms, the same distinction at the center of scaling clinical AI responsibly across service lines, care teams, and health system operations.
If your organization is weighing how to evaluate an enterprise clinical AI partner against these exact questions, including scalability, workflow integration, governance, measurable impact, and post-go-live support, we built an AI Brief around it.
Request our AI Brief: 10 Essential questions to ask when choosing enterprise clinical AI, and walk through how these criteria apply to your organization's specific AI roadmap.